Is Atrial Fibrillation a Preventable Disease?

Atrial Fibrillation

New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial

J Am Coll Cardiol.

Kosmidou I, Chen S, Kappetein AP, Serruys PW, Gersh BJ, Puskas JD, Kandzari DE, Taggart DP, Morice MC, Buszman PE, Bochenek A, Schampaert E, Pagé P, Sabik JF 3rd, McAndrew T, Redfors B, Ben-Yehuda O, Stone GW

doi: 10.1016/j.jacc.2017.12.012.

Atrial FibrillationThrombosis and Stroke

Association of Burden of Atrial Fibrillation With Risk of Ischemic Stroke in Adults With Paroxysmal Atrial Fibrillation: The KP-RHYTHM Study

JAMA Cardiol.

Go AS, Reynolds K, Yang J, Gupta N, Lenane J, Sung SH, Harrison TN, Liu TI, Solomon MD

doi: 10.1001/jamacardio.

Atrial FibrillationHeart, Artery and Coronary Diseases

Atrial Fibrillation Burden in Young Patients with Congenital Heart Disease

Circulation.

Mandalenakis Z, Rosengren A, Lappas G, Eriksson P, Gilljam T, Hansson PO, Skoglund K, Fedchenko M, Dellborg M

doi: 10.1161/CIRCULATIONAHA.

Atrial FibrillationHeart, Artery and Coronary DiseasesThrombosis and Stroke

Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial.

J Am Heart Assoc.

Hu PT, Lopes RD, Stevens SR, Wallentin L, Thomas L, Alexander JH, Hanna M, Lewis BS, Verheugt FW, Granger CB, Jones WS

doi: 10.1161/JAHA.116.004699.

Cardiovascular Risk and DiseasesAtrial FibrillationHeart FailureThrombosis and Stroke

Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force

JAMA.

Jonas DE, Kahwati LC, Yun JDY, Middleton JC, Coker-Schwimmer M, Asher GN

doi: 10.1001/jama.2018.4190.

Atrial FibrillationHeart, Artery and Coronary DiseasesMyocardial InfarctionThrombosis and Stroke

Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF-TIMI 48

Eur Heart J Acute Cardiovasc Care.

Zelniker TA, Ruff CT, Wiviott SD, Blanc JJ, Cappato R, Nordio F, Mercuri MF, Lanz H, Antman EM, Braunwald E, Giugliano RP

doi: 10.1177/

Atrial FibrillationThrombosis and StrokeTherapy and Intervention

Once-daily rivaroxaban for long-term stroke prevention in patients with atrial fibrillation

Eur Heart J Suppl.

Antoniou S, Amara W

doi: 10.1093/eurheartj/suv061.

Atrial Fibrillation

Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease

J Am Coll Cardiol.

Qamar A, Antman EM, Ruff CT, Nordio F, Murphy SA, Grip LT, Greenberger NJ, Yin OQP, Choi Y, Lanz HJ, Mercuri MF, Braunwald E, Giugliano RP

doi: 10.1016/j.jacc.2019.04.061.

Atrial FibrillationHeart, Artery and Coronary Diseases

Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease

N Engl J Med.

Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H, AFIRE Investigators.

doi: 10.1056/NEJMoa1904143.

Related content